Introduction {#Sec1}
============

Recent studies have shown that preoperative inflammation-based prognostic scores can predict the overall survival of patients with various cancers \[[@CR1]--[@CR3]\]. The systemic inflammatory response is associated with immune and coagulation processes, although the precise mechanisms that underlie this response, as well as the interaction between coagulation, inflammation, and carcinogenesis remain obscure.

The red blood cell distribution width (RDW) is the coefficient of variation in red blood cell size, and an elevated RDW corresponds to anisocytosis \[[@CR4]\]. Although its main clinical application has been limited to the diagnosis of iron deficiency anemia, fluctuations in RDW have recently been reported in many pathophysiological conditions, and elevated RDW is strongly associated with chronic inflammation, poor nutritional status, and age-associated diseases via changes in erythropoiesis. Cancer is known to evoke chronic inflammation and malnutrition, and cancer-associated inflammation is a key determinant of disease progression and survival in various cancers \[[@CR5], [@CR6]\].

Mean platelet volume (MPV), a marker of platelet size, is a platelet volume index and reflects early platelet activation \[[@CR7]\]. An elevated MPV is closely associated with thromboembolism in patients with ischemic stroke, myocardial infarction, and cerebrovascular thromboembolism \[[@CR8]--[@CR10]\]. In addition, platelets have an inflammatory role that is mediated by the secretion of pro-inflammatory factors, chemokines, and growth factors. They also have a role in cancer progression. Consequently, an inflammatory response significantly increases the risk of metastases at each cancer stage, and thus these hematological parameters predict a poor prognosis in, for example, gastric, lung, and renal cancer \[[@CR11]--[@CR13]\].

Another indicator of platelet morphology is the platelet distribution width (PDW). PDW is a measure of variation in platelet size, and a high PDW can be a sign of active platelet release. The induction of platelet production leads to an increase in the average platelet size and consequently affects the PDW. Furthermore, an elevated platelet count and increased platelet aggregation have been shown to facilitate tumor progression by protecting tumor cells from the immune system \[[@CR14]\]. PDW is therefore a potential prognostic indicator in cancer, although it should be noted that both PDW and MPV can also change in a number of benign conditions \[[@CR15], [@CR16]\].

It is now widely recognized that outcomes in cancer patients are not determined by their tumor characteristics alone, but also by non-tumor factors such as their general health \[[@CR17]\]. There is a growing interest in establishing novel predictive biomarkers for various cancers. However, to the best of our knowledge, there has been no direct analysis of the predictive value of RDW, PDW, and MPV indices in esophageal cancer. In this study, we retrospectively analyzed the clinical data of esophageal cancer patients to evaluate the impact of RDW, PDW, and MPV on cancer-specific survival (CSS).

Patients and methods {#Sec2}
====================

Patients {#Sec3}
--------

We retrospectively reviewed a database of 144 consecutive patients who underwent potentially curative esophagectomy with R0 resection for histologically verified esophageal squamous cell carcinoma at our institute between January 2006 and December 2014. R0 resection was defined as a complete resection without any microscopic resection margin involvement. Video-assisted or thoracoscopic esophagectomy with three-field lymph node dissection was performed for all patients, followed by elevation of the gastric conduit to the neck via the posterior mediastinal approach or the retrosternal approach with end-to-end anastomosis of the cervical esophagus and the gastric conduit. The clinical characteristics, laboratory data, treatment, and pathological data for the patients were obtained from their medical records. No patient had clinical signs of infection or other systemic inflammatory conditions preoperatively.

We evaluated the CSS, in which the cause of death was determined from the case notes or computerized records. Two patients who died of a complication related to surgery within 60 days after esophagectomy were excluded from the analysis. We defined 'elderly' patients as those aged ≥70 years and 'non-elderly' as those aged \<70 years \[[@CR3]\].

The observation period started from the day of the operation and lasted for 5 years or until death, loss to follow-up, or withdrawal of consent.

Permission to perform this retrospective study was obtained from the ethical board of our institution.

Blood sample analysis {#Sec4}
---------------------

Preoperative complete blood count (CBC) data were retrospectively extracted from the medical records. Only subjects for whom preoperative CBC and blood differential data were available were included in the study. All white blood cell and differential counts were taken within 1 week prior to surgery.

RDW, PDW, and MPV {#Sec5}
-----------------

CBC and hematological marker levels were measured using ethylenediaminetetraacetic acid-treated blood. Blood parameters, RDW, PDW, and MPV were analyzed using an automated hematology analyzer XE-5000 (Sysmex XE-5000 hematology analyzer; TOA Medical Electronics, Kobe, Japan). RDW, PDW, and MPV values were obtained directly from the CBC tests.

TNM stage {#Sec6}
---------

The pathological classification of the primary tumor, the degree of lymph node involvement, and the presence of organ metastasis were determined according to the TNM classification system in the 7th edition of the Cancer Staging Manual of the American Joint Committee on Cancer \[[@CR18]\].

Statistical analysis {#Sec7}
--------------------

The means and standard deviations were calculated, and the differences were analyzed using Student's *t* test. Differences between categories of each clinicopathological feature were analyzed using the chi-squared test. The routine reference cut-off values for RDW, PDW, and MPV used by our hospital laboratory were \<50, \<15.3, and \<11.5, respectively. Patients with a RDW, PDW, or MPV greater than these cut-off values were considered to have a high RDW, PDW, and MPV, while the remaining patients were considered to have a low RDW, PDW, and MPV, respectively. The CSS was calculated using Kaplan--Meier statistics, and inter-group differences were assessed using the log-rank test. CSS was defined as the interval from the date of operation to the date of cancer specific death, or last follow-up.

Univariate analyses were performed to determine variables associated with CSS. Variables with *p* values \<0.05 in the univariate analysis were included in a multivariate logistic regression analysis. The potential prognostic factors for esophageal cancer were age (\<70 vs ≥70 years), sex (female vs male), pathological stage (pStage; I/II vs III), tumor size (\<3 cm vs ≥3 cm), operation time (\<600 min vs ≥600 min), intraoperative blood loss (\<500 mL vs ≥500 mL), serum squamous cell carcinoma antigen (SCC) value (\<1.5 vs ≥1.5), RDW (\<50 vs ≥50), PDW (\<15.3 vs ≥15.3), and MPV (\<11.5 vs ≥11.5).

All statistical analyses were performed using the statistical software JMP (version 11 for Windows; SAS Institute, Cary, NC, USA), and *p* values \<0.05 were considered statistically significant.

Results {#Sec8}
=======

Relationships between RDW, PDW, MPV, and clinicopathological features {#Sec9}
---------------------------------------------------------------------

The relationships between RDW, PDW, MPV, and the clinicopathological features of 144 esophageal cancer patients are shown in Table [1](#Tab1){ref-type="table"}. The mean and standard deviation of RDW, PDW, and MPV was 48.6 ± 6.9, 11.3 ± 1.9, and 10.1 ± 0.9, respectively. Standard values of these parameters were different by measuring instrument. The routine reference cut-off values for RDW, PDW, and MPV used by our hospital laboratory were \<50, \<15.3, and \<11.5, respectively. Patients with a RDW, PDW, or MPV greater than these cut-off values were considered to have a high RDW, PDW, and MPV, while the remaining patients were considered to have a low RDW, PDW, and MPV, respectively.Table 1Relationships between RDW, PDW, MPV, and clinicopathological features in 144 patients with esophageal cancerCharacteristicsTotal patientsRDWRDWMPV\<50 (*n* = 94)≥50 (*n* = 50)*p* value\<15.3 (*n* = 140)≥15.3 (*n* = 4)*p* value\<11.5 (*n* = 132)≥11.5 (*n* = 12)*p* valueAge (years)66.3 ± 8.365.2 ± 8.30.43365.8 ± 8.369.8 ± 4.60.35265.8 ± 8.467.5 ± 6.90.498Gender0.2060.3330.084 Male129824712631209 Female15123141123Location of tumor0.0390.9050.75 Ce5145050 Ut116511092 Mt664026642615 Lt513714492474 Ae11101110101Tumor size (mm)4.3 ± 2.64.6 ± 2.40.4944.3 ± 2.56.9 ± 1.30.0434.4 ± 2.54.6 ± 2.40.718Vessel invasion0.0340.0350.451 Negative5520750705 Positive3930654627Lymphatic invasion0.0540.0620.762 Negative5115660615 Positive4335744717Differentiation0.00130.280.986 Well407470434 Moderate4835803767 Poor6813131Depth of tumor.\<0.00010.1960.06 T1a--1b6353106305670.359 21275120120 3563125533533 4a--4b13310121112Lymph node metastasis0.2730.00020.502 N0775324770725 N1422517420393 N21385112112 N31284102102Pathological stage0.0060.0320.916 1a--1b564511560524 2a--2b342113340313 3a--3c542826504495Operation time (min)655.7 ± 158.2600.8 ± 178.80.06633.8 ± 166.0738.0 ± 200.40.22634.1 ± 167.5664.5 ± 167.00.548Intraoperative blood loss (mL)550.1 ± 550.1784.7 ± 647.70.024635.8 ± 598.1485.0 ± 479.80.619633.5 ± 600.0610.8 ± 550.60.9SCC value1.18 ± 1.161.28 ± 2.390.7221.19 ± 1.692.28 ± 0.870.2021.22 ± 1.731.13 ± 1.010.847*Ce* cervical esophagus,*Ut* upper thoracic esophagus, *Mt* middle thoracic esophagus,*Lt* lower thoracic esophagus,*Ae* abdominal esophagus

There was a significant association between RDW and factors such as tumor location (*p* = 0.039), tumor depth (*p* \< 0.0001), pStage (*p* = 0.006), and intraoperative blood loss (*p* = 0.024). The PDW also showed significant associations with tumor size (*p* = 0.043), lymph node metastasis (*p* = 0.0002), and pStage (*p* = 0.032). No significant associations were found between these clinicopathological features and MPV.

Prognostic factors for CSS {#Sec10}
--------------------------

In this study, we did not analyze the relationship between PDW, MPV and prognostic value, because the size of the high PDW (*n* = 4) and the high MPV (*n* = 12) subgroup populations were too small to be compared with another group (*n* = 132).

Univariate analyses demonstrated that pStage (hazard ratio \[HR\] 4.467; 95 % confidence interval \[CI\] 2.469--8.337; *p* \< 0.0001), tumor size (HR 3.172; 95 % CI 1.511--7.076; *p* = 0.002), operation time (HR 0.497; 95 % CI 0.275--0.888; *p* = 0.018), and a high RDW (HR 2.332; 95 % CI 1.304--4.190; *p* = 0.005) were significant risk factors for a poor prognosis (Table [2](#Tab2){ref-type="table"}). In multivariate analysis, pStage (HR 3.362; 95 % CI 1.772--6.643; *p* = 0.0002) and a high RDW (HR 1.684; 95 % CI 0.929--3.071; *p* = 0.0300) were found to be independently associated with poor survival.Table 2Prognostic factors for cancer-specific survival in 144 patients with esophageal cancer after a curative esophagectomyVariablesPatients (*n* = 144)Category or characteristicsUnivariateMultivariateHR95 % CI*p* valueHR95 % CI*p* valueGender15/129(Female/male)1.2090.460--2.6420.672Age (years)47/97(\<70/≥70)1.6380.889--2.9430.112pStage90/54(I, II/III)4.4672.469--8.337\<0.00013.3621.772--6.6430.0002Tumor size45/99(\<3/≥3)3.1721.511--7.0760.0021.6570.722--4.2900.2427Operation time52/92(\<600/≥600)0.4970.275--0.8880.0180.6340.348--1.1450.1303Intraoperative blood loss71/73(\<500/≥500)1.0660.596--1.9240.830SCC value112/32(\<1.5/≥1.5)1.4680.707--2.8200.288RDW94/50(\<50/≥50)2.3321.304--4.1900.0051.6840.929--3.0710.0300

RDW, PDW, MPV, and CSS {#Sec11}
----------------------

We excluded analysis of PDW and MPV because the number of patients in the high PDW and MPV subgroups was too small to show the correct data.

Patients with a high RDW had a significantly poorer prognosis in terms of CSS than those with a low RDW (*p* = 0.004) (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Postoperative cancer-specific survival based on RDW in 144 patients with esophageal cancer

Relationships between RDW, PDW, MPV, and clinicopathological features in non-elderly patients {#Sec12}
---------------------------------------------------------------------------------------------

Significant associations were found between the RDW and factors such as tumor location (*p* = 0.022), tumor depth (*p* \< 0.0001), pStage (*p* = 0.017), and intraoperative blood loss (*p* = 0.044) (Table [3](#Tab3){ref-type="table"}), whilst the PDW only showed a significant association with lymph node metastasis (*p* = 0.008). None of the clinicopathological features were significantly associated with MPV.Table 3Relationships between RDW, PDW, MPV, and clinicopathological features in 97 non-elderly patients with esophageal cancerCharacteristicsTotal patientsRDWPDWMPV\<50 (*n* = 61)≥50 (*n* = 36)*p* value15.3\< (*n* = 95)≥15.3 (*n* = 2)*p* value11.5\< (*n* = 90)≥11.5 (*n* = 7)*p* valueAge (years)61.6 ± 5.561.2 ± 5.50.35361.3 ± 5.566.5 ± 3.50.19161.3 ± 5.563.0 ± 5.10.22Gender0.8050.6480.636 Male885533862826 Female9639081Location of tumor0.0220.7360.766 Ce4044040 Ut5325041 Mt492821472463 Lt30228300282 Ae9819081Tumor size (mm)4.2 ± 2.84.8 ± 2.50.2764.4 ± 2.78.0 ± 1.90.064.4 ± 2.75.2 ± 2.50.469Vessel invasion0.0090.1490.674 Negative3712490463 Positive2424462444Lymphatic invasion0.00070.1750.802 Negative379460433 Positive2427492474Differentiation\<0.00010.1160.893 Well282300282 Moderate3127571544 Poor278181Depth of tumor\<0.00010.2840.278 T1a--1b43394430394 26156060 3371819361361 4a-4b113810192Lymph node metastasis0.8910.0080.668 N0543519540504 N1281711280271 N26335151 N39638181Pathological stage0.0170.1910.884 1a--1b39318390363 2a--2b21129210201 3a--3c371819352343Operation time (min)645.1 ± 153.4630.4 ± 149.30.676638.2 ± 151.8707.0 ± 149.90.527638.2 ± 151.6658.3 ± 158.00.737Intraoperative blood loss (mL)545.8 ± 515.5736.9 ± 549.10.044619.5 ± 535.7485.0 ± 558.60.726612.3 ± 531.8674.3 ± 596.00.769SCC value1.14 ± 1.170.96 ± 0.670.8031.06 ± 1.021.55 ± 0.350.5041.09 ± 1.040.81 ± 0.600.485*Ce* cervical esophagus,*Ut* upper thoracic esophagus, *Mt* middle thoracic esophagus,*Lt* lower thoracic esophagus,*Ae* abdominal esophagus

Prognostic factors for CSS in non-elderly patients {#Sec13}
--------------------------------------------------

Because the total number of non-elderly patients was small, we excluded analysis of PDW and MPV.

Among non-elderly patients, univariate analysis demonstrated that pStage (HR 4.395; 95 % CI 2.059--9.933, *p* = 0.0001), tumor size (HR 5.275; 95 % CI 1.849--22.162; *p* = 0.0009), and a high RDW (HR 3.654; 95 % CI 1.716--8.241; *p* = 0.0007) were significantly associated with a worse prognosis (Table [4](#Tab4){ref-type="table"}). Multivariate analysis demonstrated that pStage (HR 2.775; 95 % CI 1.247--6.617; *p* = 0.0120), and a high RDW (HR 2.759; 95 % CI 1.282--6.284; *p* = 0.0092) were independent risk factors for a worse prognosis in non-elderly patients.Table 4Prognostic factors for cancer-specific survival in 97 non-elderly patients with esophageal cancer after a curative esophagectomyVariablesPatients (*n* = 97)Category or characteristicsUnivariateMultivariateHR95 % CI*p* valueHR95 % CI*p* valueGender9/88(Female/male)0.5260.202--1.7940.272pStage60/37(I, II/III)4.3952.059--9.9330.00012.7751.247--6.6170.012Tumor size33/64(\<3/≥3)5.2751.849--22.1620.00092.7160.862--12.0180.0919Operation time34/63(\<600/≥600)0.4870.228--1.0270.059Intraoperative blood loss46/51(\<500/≥500)1.4150.670--3.1160.365SCC value76/21(\<1.5/≥1.5)1.0510.351--2.5750.92RDW61/36(\<50/≥50)3.6541.716--8.2410.00072.7591.282--6.2840.0092

RDW and CSS in non-elderly patients {#Sec14}
-----------------------------------

Non-elderly patients with a high RDW had a significantly poorer prognosis in terms of CSS than those with a low RDW (*p* = 0.0003) (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Postoperative cancer-specific survival based on RDW in 97 non-elderly patients with esophageal cancer

Relationships between RDW, PDW, MPV and clinicopathological features in elderly patients {#Sec15}
----------------------------------------------------------------------------------------

There was a significant relationship between RDW and operation time (*p* = 0.015) (Table [5](#Tab5){ref-type="table"}), and between PDW and lymph node metastasis (*p* = 0.022). However, there were no significant associations between any of the clinicopathological features and MPV.Table 5Relationships between RDW, PDW, MPV, and clinicopathological features in 47 elderly patients with esophageal cancerCharacteristicsTotal patientsRDWPDWMPV\<50 (*n* = 33)≥50 (*n* = 14)*p* value\<15.3 (*n* = 45)≥15.3 (*n* = 2)*p* value\<11.5 (*n* = 42)≥11.5 (*n* = 5)*p* valueAge (years)75.1 ± 4.475.6 ± 4.20.63475.3 ± 4.473.0 ± 2.80.46175.4 ± 4.573.8 ± 2.30.781Gender0.0880.1070.054 Male412714401383 Female6605142Location of tumor0.6520.6390.959 Ce1101010 Ut6336051 Mt17125170152 Lt21156192192 Ae2202020Tumor size (mm)4.3 ± 2.23.9 ± 1.90.4964.2 ± 2.15.8 ± 0.70.3004.3 ± 2.13.9 ± 2.30.652Vessel invasion0.8700.1080.466 Negative188260242 Positive156192183Lymphatic invasion0.9780.2140.903 Negative146200182 Positive198252243Differentiation0.8660.3990.717 Well125170152 Moderate178232223 Poor415050Depth of tumor0.0630.380.717 T1a--1b20146200173 26606060 319136172172 4a--4b13022020Lymph node metastasis0.5980.0220.411 N077185230221 N14286140122 N213526161 N312212121Pathological stage0.3230.1580.692 1a--1b56143170161 2a--2b3494130112 3a--3c54107152152Operation time (min)675.4 ± 167.3524.6 ± 227.60.015624.4 ± 194.1769.0 ± 306.90.316625.4 ± 199.1673.2 ± 197.70.693Intraoperative blood loss (mL)558.1 ± 617.3907.5 ± 864.40.062670.0 ± 717.7485.0 ± 615.20.722678.9 ± 730.2522.0 ± 533.00.322SCC value1.25 ± 1.152.12 ± 4.390.1451.44 ± 2.603.00 ± 0.140.4051.50 ± 2.671.56 ± 1.360.519*Ce* cervical esophagus,*Ut* upper thoracic esophagus, *Mt* middle thoracic esophagus,*Lt* lower thoracic esophagus,*Ae* abdominal esophagus

Prognostic factors for CSS in elderly patients {#Sec16}
----------------------------------------------

Because the total number of elderly patients was small, we excluded analysis of PDW and MPV.

Univariate analysis demonstrated that pStage (*p* = 0.0008) was the only significant risk factor for a poor prognosis in elderly patients (Table [6](#Tab6){ref-type="table"}). RDW showed no significant association with postoperative CSS in elderly patients (*p* = 0.664) (Fig. [3](#Fig3){ref-type="fig"}).Table 6Prognostic factors for cancer-specific survival in 47 elderly patients with esophageal cancer after a curative esophagectomyVariablesPatients (*n* = 47)Category or characteristicsUnivariateMultivariateHR95 % CI*p* valueHR95 % CI*p* valueGender6/41(Female/male)1.9460.546--12.3900.338pStage30/17(I, II/III)5.3032.001--15.0630.00085.3032.001--15.0630.0008Tumor size12/35(\<3/≥3)1.4960.535--5.2880.463Operation time18/29(\<600/≥600)0.540.206--1.3720.193Intraoperative blood loss25/22(\<500/≥500)0.6660.251--1.7090.396SCC value36/11(\<1.5/≥1.5)2.1390.731--5.6570.156RDW33/14(\<50/≥50)1.2430.431--3.2160.669 Fig. 3Postoperative cancer-specific survival based on RDW in 47 elderly patients with esophageal cancer

Discussion {#Sec17}
==========

Esophageal cancer is primarily a disease of the elderly, with a peak in incidence in the eighth decade of life, and the elderly population is rapidly increasing worldwide \[[@CR19]\]. Despite recent advances in early detection, surgical techniques, and chemoradiation therapies, the prognosis of esophageal cancer remains poor. Surgery is the mainstay of treatment for this malignancy, but a considerable proportion of patients with advanced esophageal cancer develop recurrence, even after curative resection. Therefore, reliable prognostic factors that permit more accurate patient stratification are needed to improve clinical decision making for this malignancy. In addition, esophageal cancer is the eighth most common incident cancer and sixth most common cause of cancer death worldwide \[[@CR20]\]. It occurs predominantly in elderly people, the average age at the time of diagnosis continues to rise, with a peak in incidence between 70 and 75 years of age \[[@CR21]\]. CSS is an important outcome measure in elderly patients, as they are more likely to die from other age-related diseases such as cardiovascular, renal, and pulmonary diseases. As few patients actually died from causes other than cancer in this analysis, the data had a limited impact on overall survival. In addition we divided the patients into two groups in order to calculate the tendency of prognostic value by age, because the correlation between prognostic value and age was unknown until now.

RDW, which is a measure of heterogeneity in erythrocyte size, is routinely examined as part of the CBC test. In the development of iron deficiency, an elevated RDW usually precedes other blood abnormalities, such as a low red blood cell (RBC) count, a low mean corpuscular volume, and low hemoglobin levels \[[@CR22]\]. Furthermore, RDW is a more sensitive screening marker for iron deficiency than serum ferritin level, transferrin saturation, or serum iron level \[[@CR23]\]. Since the variability of RBC size increases before overt anemia, elevated RDW is a sensitive and specific indicator of early iron deficiency. In this study, we investigated the relationship between hematological parameters and CSS in esophageal cancer patients. Among these hematological parameters, we included RDW as a marker of several conditions including anemia, inflammation, and early nutritional deficiencies \[[@CR24]\]. Univariate and multivariate analyses demonstrated that a high RDW was independently associated with poor prognosis in esophageal cancer patients. These findings reflect the widely accepted hypothesis that cancer is both a cause and a result of chronic inflammation \[[@CR25], [@CR26]\].

Our findings also reveal that a high RDW is potentially an independent risk factor for a worse prognosis in non-elderly patients, but not in elderly patients. This was unexpected, but could reflect the prevalence of anemia and malnutrition in the latter. This would in turn lead to an elevated RDW, which would reduce its prognostic significance for cancer in elderly patients.

Platelets play a key role in the coagulation cascade. They also release growth factors that can contribute to tumor progression and metastasis, in part by mediating immunosuppression \[[@CR16]\]. Changes in platelet count and platelet function have been identified as part of a paraneoplastic syndrome in many cancers \[[@CR27]\], and a high platelet count was found to be closely associated with TNM stage, metastasis, and a high risk of recurrence in many types of cancer \[[@CR28], [@CR29]\]. Platelets release angiogenic growth factors, adhere to tumor microvessels, and undergo extravasation via increased vascular permeability, a process that leads to platelet activation. Increased platelet production is associated with bigger platelets, which could affect the PDW, and thus the PDW in turn may predict clinical outcome in cancer patients. However, to the best of our knowledge, the relationship between PDW and esophageal cancer has not yet been clarified. We therefore focused on PDW and CSS in esophageal cancer patients. However, we could not analyze the relationship between PDW and prognostic factors, because only a small proportion of patients had an elevated PDW, and it had a weak predictive value for clinical outcome. Further study of the predictive value of PDW is needed with a larger number of patients.

MPV is a platelet volume index and an early marker of platelet activation \[[@CR1]\]. Elevated MPV is closely associated with the severity and prognosis of malignant tumors, as well as ischemic cardiovascular disorders \[[@CR30]\]. Neoplasms are usually accompanied by thrombocytosis, which may lead to an elevated MPV and hence an increased risk of metastasis and a poor prognosis, as the tumor can produce or stimulate the production of cytokines including interleukins, interferon-, and tumor necrosis factor \[[@CR31]\]. However, the prognostic effect of MPV has not been clarified in esophageal cancer patients after curative resection. Therefore, we focused on MPV and CSS in esophageal cancer patients but could not analyze the relationship between MPV and prognostic factor. As we determined the cut-off values for RDW, PDW, and MPV to our routine laboratory data, the number of patients in the high MPV group (*n* = 12) was too small to compare with another group (*n* = 132), similar to PDW. Unfortunately, in this study we could not evaluate the prognostic value of MPV. Although platelet count is closely related to a variety of pathophysiological conditions, such as myocardial infarction, stroke, chronic inflammation, and poor nutrition, these conditions are frequently found in the elderly regardless of whether they have cancer \[[@CR32], [@CR33]\]. Furthermore, platelets are known to facilitate tumor progression by protecting them from immune responses. The present study may have failed to demonstrate a prognostic significance for MPV and PDW, because the number of patients was too small to evaluate the prognostic value for esophageal cancer. However, several clinical studies have demonstrated that MPV was elevated in patients with various carcinomas, although other studies have contradicted this \[[@CR11], [@CR34]\]. Further investigations are required to elucidate the precise mechanisms through which circulating platelets affect the prognosis of esophageal cancer patients.

In this study, we confirmed that the RDW was associated with the CSS of esophageal cancer patients after curative esophagectomy. It is particularly noteworthy that a high RDW was a significant and independent predictor of poor survival. Furthermore, in non-elderly patients, a high RDW was also an independent risk factor for a worse prognosis. We showed that a high RDW was associated with poor survival; the mean RDW was 48.6 ± 6.9 in this analysis. A high RDW may by correlated with tumor depth and pathological stage in advanced-staged esophageal cancer patients. However, this study was retrospective analysis with a small sample size. As the RDW is convenient, cost-effective and readily available as part of the routine CBC, it could act as a marker of survival in this malignancy. Thus, larger prospective studies are needed to confirm these preliminary results.

It is important to explore the risk factors for postoperative complications after esophagectomy, because they are more likely to cause complications when comparing esophagectomy with other gastrointestinal surgery. However, we could not demonstrate the predictive significance of RDW, PDW, and MPV of postoperative complication risks in this study (data not shown). We think this is because many of the patients with esophageal cancer had preoperative complications. In addition, we observed many patients who showed a high RDW after recurrence. However, we were unable to demonstrate a relationship efficacy between chemoradiotherapy and RDW, PDW or MPV after recurrence. Further studies are warranted to confirm the changes in before and after surgery effects after recurrence.

In conclusion, we confirmed that a high RDW was associated with the CSS of esophageal cancer patients after curative esophagectomy. However, a number of potential study limitations need to be taken into consideration. The cut-off value should be set by ROC analysis rather than by routine laboratory value in the data analysis. However, we performed analysis by routine laboratory values because the correct cut-off values of RDW, MPV, and PDW were uncertain, and we confirmed survival data using the hematological parameters of our routine laboratory values in this analysis. Therefore, these data should be carefully interpreted. Furthermore, this was a retrospective, single-institution design study with a small sample size and short follow-up period. Thus, larger prospective studies are required to elucidate the precise mechanisms that relate RDW, PDW and MPV to survival in esophageal cancer patients.
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